Desirable Characteristics of Hepatitis C Treatment Regimens: A Review of What We Have and What We Need

There have been dramatic advancements in the treatment of chronic hepatitis C (HCV) infection. This is largely due to the approval of several direct-acting antiviral agents (DAAs) from a variety of medication classes with novel mechanisms of action. These therapies are a welcomed advancement given t...

Descripción completa

Detalles Bibliográficos
Autores principales: Bidell, Monique R., McLaughlin, Milena, Faragon, John, Morse, Caroline, Patel, Nimish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019974/
https://www.ncbi.nlm.nih.gov/pubmed/27384319
http://dx.doi.org/10.1007/s40121-016-0118-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019974/
https://www.ncbi.nlm.nih.gov/pubmed/27384319
http://dx.doi.org/10.1007/s40121-016-0118-x

Ejemplares similares